1 day Ago By Defense World Staff
Renaissance Technologies LLC boosted its position in Inotiv, Inc. (NASDAQ:NOTV – Free Report) by 77.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.
The firm owned 304,254 shares of the company’s stock after purchasing an additional 133,190 shares during the period. Renaissance Technologies LLC owned about 1.17% of Inotiv worth $1,260,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in the business. Vantage Point Financial LLC acquired a new stake in shares of Inotiv during the 4th quarter valued at approximately $1,393,000. Perkins Capital Management Inc.
acquired a new position in Inotiv during the fourth quarter worth $497,000. Nkcfo LLC purchased a new stake in Inotiv during the fourth quarter worth $476,000. Thurston Springer Miller Herd & Titak Inc.
increased its position in shares of Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc.
now owns 127,257 shares of the company’s stock valued at $527,000 after buying an additional 109,397 shares in the last quarter. Finally, Tradewinds LLC. acquired a new position in shares of Inotiv during the 4th quarter worth $374,000.
Hedge funds and other institutional investors own 18.17% of the company’s stock. Inotiv Price PerformanceInotiv stock opened at $1.
97 on Wednesday. The company has a quick ratio of 1.28, a current ratio of 1.
57 and a debt-to-equity ratio of 2.31. The firm’s 50-day simple moving average is $2.
52 and its 200 day simple moving average is $3.25. Inotiv, Inc.
has a 52 week low of $1.15 and a 52 week high of $6.48.
The firm has a market capitalization of $66.42 million, a PE ratio of -0.43 and a beta of 3.
96. Inotiv (NASDAQ:NOTV – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported ($0.
42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10).
Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%.
On average, equities research analysts predict that Inotiv, Inc. will post -0.79 EPS for the current fiscal year.
Insider ActivityIn related news, CEO Robert Jr. Leasure sold 22,700 shares of the business’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $4.
15, for a total value of $94,205.00. Following the completion of the transaction, the chief executive officer now owns 1,030,209 shares of the company’s stock, valued at approximately $4,275,367.
35. The trade was a 2.16 % decrease in their position.
The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold 108,311 shares of company stock worth $425,330 over the last three months. 7.
80% of the stock is currently owned by corporate insiders. Inotiv Profile (Free Report)Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS).
The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.Recommended StoriesFive stocks we like better than InotivUtilities Stocks Explained – How and Why to Invest in UtilitiesDon’t Be Fooled by the Bounce: The Market Storm Isn’t Over YetAirline Stocks – Top Airline Stocks to Buy NowCoca-Cola Company Stock Can Bubble to New Highs This YearWhat is the FTSE 100 index? 3 Stocks Lifting 2025 Guidance Despite Market JittersWant to see what other hedge funds are holding NOTV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inotiv, Inc.
(NASDAQ:NOTV – Free Report)..
